This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Combined treatment with GDF15 and semaglutide resulted in greater weight loss and food intake suppression compared to either treatment alone.
Why it matters
Understanding how these treatments work can lead to more effective obesity therapies. The distinct mechanisms suggest potential for combination therapies in weight management.
How the study worked
The study used rat experiments to assess the effects of GDF15 and semaglutide on food intake and weight loss through various behavioral and neural mechanisms.
What this study cannot tell us
The study was conducted in rats, and results may not directly translate to humans.
Read the original research
Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.
Diabetes, obesity & metabolism, 24(6), 1010-1020
Citation
Ghidewon, M; Wald, H S; McKnight, A D; De Jonghe, B C; Breen, D M; Alhadeff, A L; Borner, T; Grill, H J. (2022). Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.. Diabetes, obesity & metabolism, 24(6), 1010-1020. https://doi.org/10.1111/dom.14663